Loading...
NPI 1740542893 · Aiken, SC · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Kishan Govind is a ophthalmology physician provider located in Aiken, South Carolina. This profile covers 13 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Kishan Govind |
| Address | 110 Pepper Hill Way |
| City | Aiken |
| State | SC |
| ZIP | 29801 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | June 14, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.1M |
| Medicaid | $0 |
This provider’s Medicare billing dominates its public-payer footprint: total Medicare revenue is $2.1M while Medicaid revenue is $0, indicating an effectively single‑payer (Medicare) practice with no Medicaid billing on file. That payer mix suggests payer-contracted revenue and utilization analyses should focus on Medicare performance and reimbursement trends rather than dual‑payer dynamics.
Revenue is highly concentrated in intravitreal biologic/injection codes: the precomputed top three Medicare codes (J0178, J2777, J3590) account for 87.7% of Medicare revenue, with J0178 at 44.5%, J2777 at 37.4%, and J3590 at 5.7%. These three codes alone drive the bulk of dollars, implying the practice’s economics are tightly linked to anti-VEGF and related biologic therapy volumes and reimbursement for injections.
The code mix and claim counts indicate an operation centered on retina/injection services: J0178 (aflibercept) shows 1.4K claims and $924.8K revenue, and J2777 (faricimab) shows 27.8K claims and $777.8K revenue, which together dominate clinical throughput. Coupled with imaging codes like 92134 (1.7K claims, $47.2K revenue), the pattern is consistent with a high-volume injection clinic supported by retinal diagnostics rather than a surgery-heavy or broad multispecialty ophthalmology practice.
Competitive standing on the headline biologic codes is mixed: J2777 ranks #330 of 2039 providers nationally (84th percentile; typical, unremarkable volume for this code), indicating an above-typical but not dominant share nationally; J0178 ranks #924 of 3204 (71th percentile; typical, unremarkable volume for this code), reflecting a more modest national position; J3590 ranks #399 of 631 (37th percentile; typical, unremarkable volume for this code), showing relatively low participation on unclassified biologic billing. Overall, the provider is a meaningful regional supplier of intravitreal therapy but not a national outlier.
Beyond injections, office evaluation and management and retinal imaging volumes are unusually high relative to national peers: 99214 shows 987 claims and $85.9K revenue and ranks #11797 of 479517 providers (98th percentile; notably above typical national volume for this code), 99204 ranks #5401 of 227068 (98th percentile; notably above typical), and 92134 ranks #1276 of 26868 (95th percentile; notably above typical). These elevated E/M and imaging percentiles indicate robust clinic visit throughput and diagnostic activity that support the injection-centric service line.
Pricing and revenue per-claim dynamics reinforce the biologic focus: J0178 has a reported average paid/claim of $678 and generates $924.8K in revenue from 1.4K claims, while J2777 shows $28 avg paid/claim with $777.8K revenue across 27.8K claims, and J3590 shows $2120 avg paid/claim with $118.7K revenue across 56 claims. These disparate avg paid/claim figures and concentrated revenue shares suggest the practice manages a mix of high-cost-per-claim biologics and high-claim-volume therapies, which has direct implications for inventory, billing oversight, and payer negotiations.
The provider has an established tenure in NPI records with enumeration on 2012-06-14 (~14 years ago), supporting the interpretation of a stable, mature practice rather than a recent entrant. Tenure combined with the concentrated injection and high-E/M profile implies an entrenched retina-focused outpatient practice model likely oriented around recurring biologic therapy visits and follow-up imaging.
The absence of Medicaid activity (Medicaid revenue $0) eliminates Medicaid as a material payer for network or access analyses; this lack of Medicaid billing may affect patient panel composition and indicates limited exposure to state Medicaid fee schedules and policies. Analysts should therefore treat this profile as Medicare-driven when benchmarking reimbursement risk, market share, and service-line planning.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,360 | $680 | $924.8K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 27,780 | $30 | $777.8K |
| J3590 | Unclassified biologics | 60 | $2,120 | $118.7K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,020 | $90 | $87.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 990 | $90 | $85.9K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,750 | $30 | $47.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 190 | $120 | $22.1K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 210 | $30 | $5.3K |
| 67145 | The provider prevents the detachment of the retina in the presence of small tears or thinning of the edges (lattice degeneration) by applying an intense light (such as a laser) to create scar tissue… | 20 | $160 | $3.2K |
| 92201 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 130 | $20 | $2.1K |
Showing 1–10 of 13
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
13 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 20 | 50 | 970 | $690 | $1.1M |
| J2777 | 10 | 40 | 15,960 | $30 | $594.7K |
| 67028 | 31 | 50 | 1,140 | $90 | $110.3K |
| J3590 | 2 | 10 | 60 | $1,650 | $84.4K |
| 99214 | 410 | 7,860 | 160 | $80 | $23.2K |
| 92235 | 22 | 30 | 50 | $100 | $11K |
| 92134 | 29 | 400 | 90 | $30 | $9.6K |
| 99204 | 174 | 4,520 | 40 | $110 | $6.4K |
| 67145 | 8 | 20 | 20 | $170 | $3.9K |
| 92250 | 91 | 420 | 70 | $20 | $3.5K |
Showing 1–10 of 13
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other South Carolina providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. South Carolina median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 29 | 30 | 310 | $20 | $30.9K |
Other providers in the same ZIP code as Kishan Govind, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.